These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 3435078)
1. Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles. Mesulam MM; Geula C; Morán MA Ann Neurol; 1987 Dec; 22(6):683-91. PubMed ID: 3435078 [TBL] [Abstract][Full Text] [Related]
2. Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles. Eskander MF; Nagykery NG; Leung EY; Khelghati B; Geula C Brain Res; 2005 Oct; 1060(1-2):144-52. PubMed ID: 16212945 [TBL] [Abstract][Full Text] [Related]
3. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability. Wright CI; Geula C; Mesulam MM Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355 [TBL] [Abstract][Full Text] [Related]
4. Cholinesterases within neurofibrillary tangles related to age and Alzheimer's disease. Mesulam MM; Asuncion Morán M Ann Neurol; 1987 Aug; 22(2):223-8. PubMed ID: 3662453 [TBL] [Abstract][Full Text] [Related]
5. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase. Pacheco G; Palacios-Esquivel R; Moss DE J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741 [TBL] [Abstract][Full Text] [Related]
6. Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease. Geula C; Mesulam M Brain Res; 1989 Sep; 498(1):185-9. PubMed ID: 2790472 [TBL] [Abstract][Full Text] [Related]
7. Protease inhibitors and indolamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer's disease. Wright CI; Geula C; Mesulam MM Ann N Y Acad Sci; 1993 Sep; 695():65-8. PubMed ID: 8239315 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of cholinesterase inhibitors in Alzheimer's disease. Håkansson L Acta Neurol Scand Suppl; 1993; 149():7-9. PubMed ID: 7907455 [TBL] [Abstract][Full Text] [Related]
9. In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses. Kuhl DE; Koeppe RA; Snyder SE; Minoshima S; Frey KA; Kilbourn MR Ann Neurol; 2006 Jan; 59(1):13-20. PubMed ID: 16278840 [TBL] [Abstract][Full Text] [Related]
10. Effect of in vivo microdialysis of 1,2,3,4-tetrahydro-9-aminoacridine (THA) on the extracellular concentration of acetylcholine in the striatum of anesthetized rats. Xiao WB; Nordberg A; Zhang X J Pharmacol Exp Ther; 1993 May; 265(2):759-64. PubMed ID: 8496822 [TBL] [Abstract][Full Text] [Related]
11. Protease inhibitors and indoleamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer disease. Wright CI; Guela C; Mesulam MM Proc Natl Acad Sci U S A; 1993 Jan; 90(2):683-6. PubMed ID: 8421706 [TBL] [Abstract][Full Text] [Related]
12. [Importance of neurofibrillary degeneration in the diagnosis of Alzheimer's disease]. Gómez-Ramos P; Jiménez A; Cebrián JL; Morán MA Med Clin (Barc); 1993 Jun; 101(2):60-3. PubMed ID: 8510479 [TBL] [Abstract][Full Text] [Related]
13. [Diagnosis of Alzheimer's disease. Evaluation of senile plaques of the diffuse type]. Morán MA; Cebrián JL; Gómez-Ramos P; Cabello A; Madero S; Mufson EJ Med Clin (Barc); 1992 Jan; 98(1):19-23. PubMed ID: 1545606 [TBL] [Abstract][Full Text] [Related]
14. The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro. Hunter AJ; Murray TK; Jones JA; Cross AJ; Green AR Br J Pharmacol; 1989 Sep; 98(1):79-86. PubMed ID: 2804555 [TBL] [Abstract][Full Text] [Related]
15. 9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ current. Drukarch B; Kits KS; Van der Meer EG; Lodder JC; Stoof JC Eur J Pharmacol; 1987 Sep; 141(1):153-7. PubMed ID: 2444444 [TBL] [Abstract][Full Text] [Related]
17. Alternatives in the treatment of memory loss in patients with Alzheimer's disease. Volger BW Clin Pharm; 1991 Jun; 10(6):447-56. PubMed ID: 2065522 [TBL] [Abstract][Full Text] [Related]
18. Cholinesterases in the amyloid angiopathy of Alzheimer's disease. Mesulam M; Carson K; Price B; Geula C Ann Neurol; 1992 May; 31(5):565-9. PubMed ID: 1375822 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease. Shao D; Zou C; Luo C; Tang X; Li Y Bioorg Med Chem Lett; 2004 Sep; 14(18):4639-42. PubMed ID: 15324879 [TBL] [Abstract][Full Text] [Related]
20. Multiple actions of THA on cholinergic neurotransmission in Alzheimer brains. Nordberg A; Nilsson-Håkansson L; Adem A; Lai Z; Winblad B Prog Clin Biol Res; 1989; 317():1169-78. PubMed ID: 2557636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]